Related Experiment Video
Updated: Jan 30, 2026

Preparation and Evaluation of 99mTc-labeled Tridentate Chelates for Pre-targeting Using Bioorthogonal Chemistry
Published on: February 4, 2017
Cholecystokinin-2 Receptor Targeting with Novel C-terminally Stabilized HYNIC-Minigastrin Analogs Radiolabeled with
Maximilian Klingler1, Christine Rangger2, Dominik Summer3
1Department of Nuclear Medicine, Medical University of Innsbruck, Anichstrasse 35, A-6020 Innsbruck, Austria. maximilian.klingler@i-med.ac.at.
Abstract:
The high overexpression of cholecystokinin-2 receptors (CCK2R) in tumors, such as medullary thyroid carcinoma, allows for highly specific diagnostic and therapeutic targeting with radiolabeled peptide probes derived from natural ligands for the receptor. Based on the ideal imaging characteristics, high availability and low cost of technetium-99m (99mTc)-labeled radiopharmaceuticals we have developed two hydrazinonicotinic acid (HYNIC) conjugated minigastrin analogs allowing labeling at high specific activity. The CCK2R targeting peptide conjugates show specific amino acid substitutions in the C-terminal receptor-specific sequence with the aim to increase stability and tumor targeting. The CCK2R affinity and the cell uptake of the new radioligands were analyzed using A431 human epidermoid carcinoma cells stably transfected with human CCK2R and mock transfected cells. Metabolic studies in BALB/c mice revealed a high resistance against enzymatic degradation for both radioligands. Biodistribution studies in tumor-xenografted athymic BALB/c nude mice at 1 h and 4 h p.i. showed that the two 99mTc-labeled compounds showed varying uptake in receptor expressing organs, stomach and pancreas (1.3⁻10.4% IA/g), as well as kidneys, the main route of excretion (7.8⁻19.9% IA/g). The tumor uptake in A431-CCK2R xenografts was 24.75 ± 4.38% IA/g for [99mTc]Tc-HYNIC-MGS5 and 42.48 ± 6.99% IA/g for [99mTc]Tc-HYNIC-MGS11 at 4 h p.i., whereas the tumor-to-kidney ratio was comparable (2.6⁻3.3). On demand availability and potential application for radioguided surgery of a 99mTc-labeled minigastrin analog support the further evaluation of these highly promising new compounds.
Insights
New technetium-99m (99mTc)-labeled minigastrin analogs show promise for targeting cholecystokinin-2 receptors (CCK2R) in tumors. These radioligands demonstrate high tumor uptake and stability, supporting their potential for cancer diagnosis and therapy.
Area of Science:
- Nuclear Medicine
- Radiopharmaceutical Chemistry
- Oncology
Background:
- Overexpression of cholecystokinin-2 receptors (CCK2R) in tumors like medullary thyroid carcinoma enables targeted imaging and therapy.
- Technetium-99m (99mTc)-labeled radiopharmaceuticals offer ideal imaging characteristics, availability, and cost-effectiveness.
Purpose of the Study:
- To develop and evaluate novel hydrazinonicotinic acid (HYNIC) conjugated minigastrin analogs for CCK2R-targeted imaging.
- To assess the stability, tumor targeting, and biodistribution of two new 99mTc-labeled peptide conjugates.
Main Methods:
- Synthesis of two HYNIC-conjugated minigastrin analogs with specific amino acid substitutions.
- Labeling with 99mTc at high specific activity.
- In vitro analysis of CCK2R affinity and cell uptake using A431 cells (CCK2R-transfected and mock-transfected).
- In vivo metabolic stability studies in BALB/c mice.
- Biodistribution studies in athymic BALB/c nude mice bearing A431-CCK2R xenografts.
Main Results:
- Both radioligands exhibited high resistance to enzymatic degradation in vivo.
- Significant tumor uptake was observed: 24.75 ± 4.38% IA/g for [99mTc]Tc-HYNIC-MGS5 and 42.48 ± 6.99% IA/g for [99mTc]Tc-HYNIC-MGS11 at 4 hours post-injection.
- Tumor-to-kidney ratios were comparable (2.6–3.3), with kidneys showing high excretion (7.8–19.9% IA/g).
Conclusions:
- The developed 99mTc-labeled minigastrin analogs demonstrate excellent stability and high tumor targeting capabilities for CCK2R-expressing xenografts.
- These compounds show potential for diagnostic imaging and therapeutic applications in CCK2R-positive cancers.
- Further evaluation is warranted for their potential use in radioguided surgery.
More Related Videos
Related Concept Videos
Termination of Translation
Termination of Translation
Nuclear Stability
To hold positively charged protons together...
RNA Stability
Internal Receptors
G-protein Coupled Receptors

